Skip to main content

BNP PARIBAS ARBITRAGE, SA

Position in QNCX — Quince Therapeutics, Inc.

CIK 1166588 NEW YORK, NY

Position in QNCX

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$1
-$25 QoQ
Shares Held
0
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
22 quarters on record

Common Shares in QNCX Over Time

Shares Held

Position Value (USD)

Derivatives in QNCX

reported options exposure · as of Dec 31, 2020
CallValue
$0
CallShares
0
PutValue
$2,083
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BNP PARIBAS ARBITRAGE, SA holds $3,275,701,265 across 414 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in QNCX

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1 8
2025-12-31 $26 8
2025-09-30 $13 8
2025-06-30 $13 8
2024-06-30 $18 24
2024-03-31 $25 24
2023-12-31 $25 24
2023-09-30 $66 59
2023-06-30 $88 59
2023-03-31 $1,009 647
2022-12-31 $770 1,209
2022-09-30 $275,665 207,267
2022-06-30 $633,861 285,523
2022-03-31 $2,035,494 328,836
2021-12-31 $2,266,716 179,613
2021-09-30 $328,876 3,588
2021-06-30 $39,061 737
2021-03-31 $114,323 3,173
2020-12-31 $193,709 6,973
2020-12-31 $2,083 75
2020-09-30 $186,550 3,731
2020-06-30 $31,391 678
2020-03-31 $158,403 3,473